Tandem Diabetes Care Inc (TNDM): Cost of Revenue
$468.72M
Year ended 2025-12-31
$458.10M
Trailing 12 months to 2026-06-30
+6.5%
3-year compound annual growth
+14.5%
5-year compound annual growth
+26.1%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $468.72M | +4.0% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $450.63M | +18.6% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $380.03M | -2.1% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $388.23M | +18.9% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $326.58M | +37.0% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $238.31M | +41.8% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $168.09M | +78.7% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $94.04M | +48.1% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $63.51M | +4.7% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $60.66M | +31.1% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $46.27M | +34.2% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $34.47M | +50.9% | 2017-03-08, From 2014-01-01 |
| 2013-12-31 | $22.84M | +497.4% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $3.82M | n/a | 2015-02-24, From 2012-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $468.72M | +4.0% |
| Embecta Corp. (EMBC) | 2025-09-30 | $403.60M | +4.0% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $133.22M | +8.3% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $256.30M | +1.1% |
| Haemonetics Corp (HAE) | 2026-03-28 | $546.44M | -10.7% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $232.27M | +24.0% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $219.89M | +19.3% |
| Penumbra Inc (PEN) | 2025-12-31 | $461.23M | +4.9% |
| Merit Medical Systems Inc (MMSI) | 2025-12-31 | $777.64M | +9.0% |
Compare TNDM, EMBC, INSP, OFIX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗